The pathogenesis of cystinosis: Mechanisms beyond cystine accumulation

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 5, 2010, Pages

  Wilmer, Martijn J ^a,b   Emma, Francesco ^c   Levtchenko, Elena N ^b,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cystine transport; Fanconi syndrome; Glutathione

Indexed keywords

CARRIER PROTEIN; CYSTINE; CYSTINOSIN; MERCAPTAMINE; UNCLASSIFIED DRUG;

CYSTINOSIS; FANCONI RENOTUBULAR SYNDROME; GENE MUTATION; HUMAN; KIDNEY FAILURE; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; LIFE EXPECTANCY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 78349266424     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00318.2010     Document Type: Review

References (148)

1. Abderhalden E. Familiäre cystindiathese. Hopp Seylers Zeitschr Physiol Chemie 38: 557-561, 1903.
2. Alcantara-Ortigoza MA, Belmont-Martinez L, Vela-Amieva M, Gonzalez-Del A. Analysis of the CTNS gene in nephropathic cystinosis Mexican patients: report of four novel mutations and identification of a false positive 57-kb deletion genotype with LDM-2/exon 4 multiplex PCR assay. Genet Test 12: 409-414, 2008.
3. Anikster Y, Lucero C, Touchman JW, Huizing M, McDowell G, Shotelersuk V, Green ED, Gahl WA. Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab 66: 111-116, 1999. (Pubitemid 29390215)
4. Anikster Y, Shotelersuk V, Gahl WA. CTNS mutations in patients with cystinosis. Hum Mutat 14: 454-458, 1999.
5. Attard M, Jean G, Forestier L, Cherqui S, Van't Hoff W, Broyer M, Antignac C, Town M. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet 8: 2507-2514, 1999.
6. Beck M, Barone R, Hoffmann R, Kratzer W, Rakowsky T, Nigro F, Fiumara A. Inter- and intrafamilial variability in mucolipidosis II (I-cell disease). Clin Genet 47: 191-199, 1995.
7. Bellomo F, Corallini S, Pastore A, Palma A, Laurenzi C, Emma F, Taranta A. Modulation of CTNS gene expression by intracellular thiols. Free Radic Biol Med 48: 865-872, 2010.
8. 1 cells. Am J Physiol Cell Physiol 263: C516-C520, 1992.
9. Bens M, Vandewalle A. Cell models for studying renal physiology. Pflügers Arch 457: 1-15, 2008.
10. Bocca G, Monnens LA. Defective proximal tubular function in a patient with I-cell disease. Pediatr Nephrol 18: 830-832, 2003.
11. Bockenhauer D, Rees L, van't Hoff W. An association of tubular dysfunction, cortical macrocysts and chronic kidney disease. Pediatr Nephrol 21: 580-583, 2006.
12. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352, 1998.
13. Broyer M, Guillot M, Gubler MC, Habib R. Infantile cystinosis: a reappraisal of early and late symptoms. Adv Nephrol Necker Hosp 10: 137-166, 1981.
14. Camargo SM, Bockenhauer D, Kleta R. Aminoacidurias: clinical and molecular aspects. Kidney Int 73: 918-925, 2008.
15. Chabli A, Aupetit J, Raehm M, Ricquier D, Chadefaux-Vekemans B. Measurement of cystine in granulocytes using liquid chromatography-tandem mass spectrometry. Clin Biochem 40: 692-698, 2007.
16. Charnas LR, Bernardini I, Rader D, Hoeg JM, Gahl WA. Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med 324: 1318-1325, 1991.
17. Cherqui S, Kalatzis V, Trugnan G, Antignac C. The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif. J Biol Chem 276: 13314-13321, 2001. (Pubitemid 37385263)
18. Cherqui S, Sevin C, Hamard G, Kalatzis V, Sich M, Pequignot MO, Gogat K, Abitbol M, Broyer M, Gubler MC, Antignac C. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Mol Cell Biol 22: 7622-7632, 2002.
19. Chevalier RL, Forbes MS. Generation and evolution of atubular glomeruli in the progression of renal disorders. J Am Soc Nephrol 19: 197-206, 2008.
20. Chol M, Nevo N, Cherqui S, Antignac C, Rustin P. Glutathione precursors replenish decreased glutathione pool in cystinotic cell lines. Biochem Biophys Res Commun 324: 231-235, 2004.
21. Choudhury R, Diao A, Zhang F, Eisenberg E, Saint-Pol A, Williams C, Konstantakopoulos A, Lucocq J, Johannes L, Rabouille C, Greene LE, Lowe M. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol Biol Cell 16: 3467-3479, 2005.
22. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3: 256-266, 2002.
23. Christensen EI, Devuyst O, Dom G, Nielsen R, Van der SP, Verroust P, Leruth M, Guggino WB, Courtoy PJ. Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci USA 100: 8472-8477, 2003.
24. Coor C, Salmon RF, Quigley R, Marver D, Baum M. Role of adenosine-triphosphate (ATP) and NaK ATPase in the inhibition of proximal tubule transport with intracellular cystine loading. J Clin Invest 87: 955-961, 1991.
25. Coudroy G, Gburek J, Kozyraki R, Madsen M, Trugnan G, Moestrup SK, Verroust PJ, Maurice M. Contribution of cubilin and amnionless to processing and membrane targeting of cubilin-amnionless complex. J Am Soc Nephrol 16: 2330-2337, 2005.
26. Cui S, Guerriero CJ, Szalinski CM, Kinlough CL, Hughey RP, Weisz OA. OCRL1 function in renal epithelial membrane traffic. Am J Physiol Renal Physiol 298: F335-F345, 2010.
27. Danpure CJ, Jennings PR, Fyfe DA. Further studies on the effect of chloroquine on the uptake, metabolism and intracellular translocation of [35S]cystine in cystinotic fibroblasts. Biochim Biophys Acta 885: 256-265, 1986.
28. De Toni G. Remarks on the relations between renal rickets (renal dwarfism) and renal diabetes. Acta Paediatrica 16: 479-484, 1933.
29. Debre R, Marie J, Cleret J, Messimy R. Rachitisme tardif coexistant avec une nephrite chronique et une glycosurie. Arch Med Enfants 37: 597-606, 1934.
30. Detrisac CJ, Mayfield RK, Colwell JA, Garvin AJ, Sens DA. In vitro culture of cells exfoliated in the urine by patients with diabetes mellitus. J Clin Invest 71: 170-173, 1983.
31. Diomedi-Camassei F, Di GS, Santorelli FM, Caridi G, Piemonte F, Montini G, Ghiggeri GM, Murer L, Barisoni L, Pastore A, Muda AO, Valente ML, Bertini E, Emma F. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 18: 2773-2780, 2007.
32. Evers R, Zaman GJ, van DL, Jansen H, Calafat J, Oomen LC, Oude Elferink RP, Borst P, Schinkel AH. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest 97: 1211-1218, 1996.
33. Fanconi G. Die nicht diabetischen glykosurien und hyperglykamiendes altem kindes. Jahrbuch Kinderheilkunde 133: 257-300, 1931.
34. Fanconi G, Bickel H. Die chronische aminoacidurie (aminosaurediabetes oder nephrotisch-glukosurischer zwergwuchs) bei der glykogenose und der cystinkrankheit. Helv Pediatr Acta 4: 359-396, 1949.
35. Feliubadalo L, Font M, Purroy J, Rousaud F, Estivill X, Nunes V, Golomb E, Centola M, Aksentijevich I, Kreiss Y, Goldman B, Pras M, Kastner DL, Pras E, Gasparini P, Bisceglia L, Beccia E, Gallucci M, de SL, Ponzone A, Rizzoni GF, Zelante L, Bassi MT, George AL Jr, Manzoni M, De GA, Riboni M, Endsley JK, Ballabio A, Borsani G, Reig N, Fernandez E, Estevez R, Pineda M, Torrents D, Camps M, Lloberas J, Zorzano A, Palacin M. Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT. Nat Genet 23: 52-57, 1999.
36. Fernandez E, Torrents D, Chillaron J, Martin Del RR, Zorzano A, Palacin M. Basolateral LAT-2 has a major role in the transepithelial flux of L-cystine in the renal proximal tubule cell line OK. J Am Soc Nephrol 14: 837-847, 2003.
37. Fernandez-Valero EM, Ballart A, Iturriaga C, Lluch M, Macias J, Vanier MT, Pineda M, Coll MJ. Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients: genotype-phenotype correlations. Clin Genet 68: 245-254, 2005.
38. Foreman JW, Bowring MA, Lee J, States B, Segal S. Effect of cystine dimethylester on renal solute handling and isolated renal tubule transport in the rat - a new model of the Fanconi syndrome. Metabolism 36: 1185-1191, 1987.
39. Forestier L, Jean G, Attard M, Cherqui S, Lewis C, Van't Hoff W, Broyer M, Town M, Antignac C. Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay. Am J Hum Genet 65: 353-359, 1999.
40. Franco R, Cidlowski JA. SLCO/OATP-like transport of glutathione in FasL-induced apoptosis: glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis. J Biol Chem 281: 29542-29557, 2006.
41. Frank H, Groger N, Diener M, Becker C, Braun T, Boettger T. Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice. J Biol Chem 283: 24729-24737, 2008.
42. Frey IM, Rubio-Aliaga I, Siewert A, Sailer D, Drobyshev A, Beckers J, de Angelis MH, Aubert J, Bar HA, Fiehn O, Eichinger HM, Daniel H. Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice. Physiol Genomics 28: 301-310, 2007. (Pubitemid 46708770)
43. Gahl WA, Balog JZ, Kleta R. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intern Med 147: 242-250, 2007.
44. Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD. Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 217: 1263-1265, 1982.
45. Gahl WA, Thoene JG, Schneider JA. Cystinosis: a disorder of lysosomal membrane transport. In: The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York: McGraw-Hill, 2001, p. 5085-6108.
46. Gahl WA, Thoene JG, Schneider JA. Cystinosis. N Engl J Med 347: 111-121, 2002.
47. Gahl WA, Tietze F, Bashan N, Steinherz R, Schulman JD. Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes. J Biol Chem 257: 9570-9575, 1982.
48. Gahl WA, Tietze F, Butler JD, Schulman JD. Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange. Biochem J 228: 545-550, 1985.
49. Gibson A, Futter CE, Maxwell S, Allchin EH, Shipman M, Kraehenbuhl JP, Domingo D, Odorizzi G, Trowbridge IS, Hopkins CR. Sorting mechanisms regulating membrane protein traffic in the apical transcytotic pathway of polarized MDCK cells. J Cell Biol 143: 81-94, 1998.
50. Goldman H, Scriver CR, Aaron K, Pinsky L. Use of dithiothreitol to correct cystine storage in cultured cystinotic fibroblasts. Lancet 1: 811-812, 1970.
51. Goldman R, Kaplan A. Rupture of rat-liver lysosomes mediated by L-amino-acid esters. Biochim Biophys Acta 318: 205-216, 1973.
52. Graaf-Hess A, Trijbels F, Blom H. New method for determining cystine in leukocytes and fibroblasts. Clin Chem 45: 2224-2228, 1999.
53. Gubler M, Lacoste M, Sich M, Broyer M. The pathology of the kidney in cystinosis. In: Cystinosis, edited by Broyer M. Paris: Elsevier, 1999, p. 42-48.
54. Hall AM, Unwin RJ. The not so 'mighty chondrion': emergence of renal diseases due to mitochondrial dysfunction. Nephron Physiol 105: 1-10, 2007.
55. Hintz DS, Sens MA, Jenkins MQ, Sens DA. Tissue culture of epithelial cells from urine. I. Serum-free growth of cells from newborn infants. Pediatr Pathol 2: 153-163, 1984.
56. Hippert C, Dubois G, Morin C, Disson O, Ibanes S, Jacquet C, Schwendener R, Antignac C, Kremer EJ, Kalatzis V. Gene transfer may be preventive but not curative for a lysosomal transport disorder. Mol Ther 16: 1372-1381, 2008.
57. Hollak CE, van WS, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93: 1288-1292, 1994.
58. Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, Nussbaum RL and Scheinman SJ. Dent disease with mutations in OCRL1. Am J Hum Genet 76: 260-267, 2005.
59. Jackson JD, Smith F, Litman N, Yuile C, Latta H. The Fanconi syndrome with cystinossis. Electron microscopy of renal biopsy specimens from five patients. Am J Med 33: 893-910, 1962.
60. Jonas AJ, Smith ML, Allison WS, Laikind PK, Greene AA, Schneider JA. Proton-translocating ATPase and lysosomal cystine transport. J Biol Chem 258: 11727-11730, 1983.
61. Jonas AJ, Smith ML, Schneider JA. ATP-dependent lysosomal cystine efflux is defective in cystinosis. J Biol Chem 257: 3185-3188, 1982.
62. +-driven lysosomal cystine transporter. EMBO J 20: 5940-5949, 2001.
63. Kalatzis V, Nevo N, Cherqui S, Antignac C. Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin. Hum Mol Genet 13: 1361-1371, 2004.
64. Kalatzis V, Serratrice N, Hippert C, Payet O, Arndt C, Cazevieille C, Maurice T, Hamel C, Malecaze F, Antignac C, Muller A, Kremer EJ. The ocular anomalies in a cystinosis animal model mimic disease pathogenesis. Pediatr Res 62: 156-162, 2007.
65. Kirlin WG, Cai J, Thompson SA, Diaz D, Kavanagh TJ, Jones DP. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med 27: 1208-1218, 1999.
66. Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA. Long-term follow-up of well-treated nephropathic cystinosis patients. J Pediatr 145: 555-560, 2004.
67. Kornfeld S, Sly WS. I-cell disease and pseudo-Hurler polydystrophy: disorders of lysosomal enzyme phosphorylation and localization. In: The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York: McGraw-Hill, 1995, p. 2495-2508.
68. Kralik PM, Long Y, Song Y, Yang L, Wei H, Coventry S, Zheng S, Epstein PN. Diabetic albuminuria is due to a small fraction of nephrons distinguished by albumin-stained tubules and glomerular adhesions. Am J Pathol 175: 500-509, 2009.
69. Kroll WA, Schneider JA. Decrease in free cystine content of cultured cystinotic fibroblasts by ascorbic acid. Science 186: 1040-1042, 1974.
70. Lash LH. Role of glutathione transport processes in kidney function. Toxicol Appl Pharmacol 204: 329-342, 2005.
71. Laube GF, Shah V, Stewart VC, Hargreaves IP, Haq MR, Heales SJ, van't Hoff WG. Glutathione depletion and increased apoptosis rate in human cystinotic proximal tubular cells. Pediatr Nephrol 21: 503-509, 2006.
72. Lebre AS, Moriniere V, Dunand O, Bensman A, Morichon-Delvallez N, Antignac C. Maternal uniparental heterodisomy of chromosome 17 in a patient with nephropathic cystinosis. Eur J Hum Genet 17: 1019-1023, 2009.
73. Levtchenko E, Blom H, Wilmer M, van den Heuvel L, Monnens L. ACE inhibitor enalapril diminishes albuminuria in patients with cystinosis. Clin Nephrol 60: 386-389, 2003.
74. Levtchenko EN, Graaf-Hess A, Blom HJ, Monnens LA. Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome. Clin Nephrol 57: 349-351, 2002.
75. Levtchenko EN, Wilmer MJ, Kluijtmans LA, Monnens LA, van den Heuvel LP. Cysteamine treatment in cystinotic proximal tubular cells increases intracellular glutathione without restoring decreased ATP levels (Abstract). J Am Soc Nephrol 20: 283A, 2009.
76. Levtchenko EN, Wilmer MJG, Janssen AJM, Koenderink JB, Visch HJ, Willems PHGM, Graaf-Hess A, Blom HJ, van den Heuvel LP, Monnens LA. Decreased intracellular ATP content and intact mitochondrial energy generating capacity in human cystinotic fibroblasts. Pediatr Res 59: 287-292, 2006. (Pubitemid 43841004)
77. Lignac GOE. Ueber Storung des Cystinstoffwechsels bei Kindern. Deut Arch Klin Med 145: 139-150, 1924.
78. Luzio JP, Pryor PR, Bright NA. Lysosomes: fusion and function. Nat Rev Mol Cell Biol 8: 622-632, 2007.
79. Mahoney CP, Striker GE. Early development of the renal lesions in infantile cystinosis. Pediatr Nephrol 15: 50-56, 2000.
80. Mannucci L, Pastore A, Rizzo C, Piemonte F, Rizzoni G, Emma F. Impaired activity of the gamma-glutamyl cycle in nephropathic cystinosis fibroblasts. Pediatr Res 59: 332-335, 2006.
81. Markovich D, Verri T, Sorribas V, Forgo J, Biber J, Murer H. Regulation of opossum kidney (OK) cell Na/Pi cotransport by Pi deprivation involves mRNA stability. Pflügers Arch 430: 459-463, 1995.
82. Medlar A, Kleta R. Cystinosis and mickey mouse. Nephrol Dial Transplant 25: 1032-1033, 2010.
83. Miyauchi S, Gopal E, Babu E, Srinivas SR, Kubo Y, Umapathy NS, Thakkar SV, Ganapathy V, Prasad PD. Sodium-coupled electrogenic transport of pyroglutamate (5-oxoproline) via SLC5A8, a monocarboxylate transporter. Biochim Biophys Acta 1798: 1164-1171, 2010.
84. Monnens L, Levtchenko E. Evaluation of the proximal tubular function in hereditary renal Fanconi syndrome. Nephrol Dial Transplant 23: 2719-2722, 2008.
85. Moran A, Ben-Nun A, Potashnik R, Bashan N. Renal cells in culture as a model for cystinosis. J Basic Clin Physiol Pharmacol 1: 357-372, 1990.
86. Morava E, Rodenburg RJ, Hol F, De Vries M, Janssen A, van den Heuvel L, Nijtmans L, Smeitink J. Clinical and biochemical characteristics in patients with a high mutant load of the mitochondrial T8993G/C mutations. Am J Med Genet A 140: 863-868, 2006.
87. Motoyoshi Y, Matsusaka T, Saito A, Pastan I, Willnow TE, Mizutani S, Ichikawa I. Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria. Kidney Int 74: 1262-1269, 2008.
88. Nesterova G, Gahl WA. Cystinosis. In: GeneReviews, edited by Pagon RA, Bird TC, Dolan CR, and Stephens K. Seattle, WA: Univ. of Washington, 2010, p. 1993-2001.
89. Nevo N, Chol M, Bailleux A, Kalatzis V, Morisset L, Devuyst O, Gubler MC, Antignac C. Renal phenotype of the cystinosis mouse model is dependent upon genetic background. Nephrol Dial Transplant 25: 1059-1066, 2010.
90. Niaudet P. Mitochondrial disorders and the kidney. Arch Dis Child 78: 387-390, 1998.
91. Nielsen R, Courtoy PJ, Jacobsen C, Dom G, Lima WR, Jadot M, Willnow TE, Devuyst O, Christensen EI. Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells. Proc Natl Acad Sci USA 104: 5407-5412, 2007.
92. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 87: 165-217, 2007.
93. Njalsson R, Ristoff E, Carlsson K, Winkler A, Larsson A, Norgren S. Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency. Hum Genet 116: 384-389, 2005.
94. Norden AG, Lapsley M, Igarashi T, Kelleher CL, Lee PJ, Matsuyama T, Scheinman SJ, Shiraga H, Sundin DP, Thakker RV, Unwin RJ, Verroust P, Moestrup SK. Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome. J Am Soc Nephrol 13: 125-133, 2002.
95. Okamura DM, Himmelfarb J. Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease. Pediatr Nephrol 24: 2309-2319, 2009.
96. Park M, Helip-Wooley A, Thoene J. Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells. J Am Soc Nephrol 13: 2878-2887, 2002.
97. Park MA, Pejovic V, Kerisit KG, Junius S, Thoene JG. Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of protein kinase Cdelta. J Am Soc Nephrol 17: 3167-3175, 2006.
98. Patrick AD, Lake BD. Cystinosis: electron microscopic evidence of lysosomal storage of cystine in lymph node. J Clin Pathol 21: 571-575, 1968.
99. Pellett OL, Smith ML, Thoene JG, Schneider JA, Jonas AJ. Renal cell culture using autopsy material from children with cystinosis. In Vitro 20: 53-58, 1984.
100. Peng J, Li YJ. The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection. Eur J Pharmacol 627: 1-7, 2010.
101. Periyasamy-Thandavan S, Jiang M, Schoenlein P, Dong Z. Autophagy: molecular machinery, regulation, and implications for renal pathophysiology. Am J Physiol Renal Physiol 297: F244-F256, 2009.
102. Phornphutkul C, Anikster Y, Huizing M, Braun P, Brodie C, Chou JY, Gahl WA. The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, carkl, and causes cystinosis if mutated in a critical region. Am J Hum Genet 69: 712-721, 2001.
103. Pisoni RL, Thoene JG, Lemons RM, Christensen HN. Important differences in cationic amino acid transport by lysosomal system c and system y+ of the human fibroblast. J Biol Chem 262: 15011-15018, 1987.
104. --channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408: 369-373, 2000.
105. Pras E, Raben N, Golomb E, Arber N, Aksentijevich I, Schapiro JM, Harel D, Katz G, Liberman U, Pras M. Mutations in the SLC3A1 transporter gene in cystinuria. Am J Hum Genet 56: 1297-1303, 1995.
106. Racusen LC, Fivush BA, Andersson H, Gahl WA. Culture of renal tubular cells from the urine of patients with nephropathic cystinosis. J Am Soc Nephrol 1: 1028-1033, 1991.
107. Racusen LC, Wilson PD, Hartz PA, Fivush BA, Burrow CR, Philip ET. Renal proximal tubular epithelium from patients with nephropathic cystinosis - immortalized cell lines as in vitro model systems. Kidney Int 48: 536-543, 1995.
108. Reeves JP. Accumulation of amino acids by lysosomes incubated with amino acid methyl esters. J Biol Chem 254: 8914-8921, 1979.
109. Ristoff E, Larsson A. Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis 2: 16, 2007.
110. Rizzo C, Ribes A, Pastore A, Dionisi-Vici C, Greco M, Rizzoni G, Federici G. Pyroglutamic aciduria and nephropathic cystinosis. J Inherit Metab Dis 22: 224-226, 1999.
111. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok- Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48-57, 1994.
112. Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol 10: 623-635, 2009.
113. Salmon RF, Baum M. Intracellular cystine loading inhibits transport in the rabbit proximal convoluted tubule. J Clin Invest 85: 340-344, 1990.
114. Sansanwal P, Kambham N, Sarwal MM. Caspase-4 may play a role in loss of proximal tubules and renal injury in nephropathic cystinosis. Pediatr Nephrol 2009, ePub.
115. Sansanwal P, Yen B, Gahl WA, Ma Y, Ying L, Wong LJ, Sarwal MM. Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol 21: 272-283, 2010.
116. Santangelo F, Witko-Sarsat V, Drueke T, Descamps-Latscha B. Restoring glutathione as a therapeutic strategy in chronic kidney disease. Nephrol Dial Transplant 19: 1951-1955, 2004.
117. Santo Y, Hirai H, Shima M, Yamagata M, Michigami T, Nakajima S, Ozono K. Examination of megalin in renal tubular epithelium from patients with Dent disease. Pediatr Nephrol 19: 612-615, 2004. (Pubitemid 38771730)
118. Schneider JA, Bradley K, Seegmiller JE. Increased cystine in leukocytes from individuals homozygous and heterozygous for cystinosis. Science 157: 1321-1322, 1967.
119. Schneider JA, Rosenbloom FM, Bradley KH, Seegmiller JE. Increased free-cystine content of fibroblasts cultured from patients with cystinosis. Biochem Biophys Res Commun 29: 527-531, 1967.
120. Schulman JD, Bradley KH, Seegmiller JE. Cystine: compartmentalization within lysosomes in cystinotic leukocytes. Science 166: 1152-1154, 1969.
121. Servais A, Moriniere V, Grunfeld JP, Noel LH, Goujon JM, Chadefaux-Vekemans B, Antignac C. Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping. Clin J Am Soc Nephrol 3: 27-35, 2008.
122. Shah SV, Baliga R, Rajapurkar M, Fonseca VA. Oxidants in chronic kidney disease. J Am Soc Nephrol 18: 16-28, 2007.
123. Steinherz R, Tietze F, Gahl WA, Triche TJ, Chiang H, Modesti A, Schulman JD. Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci USA 79: 4446-4450, 1982. (Pubitemid 12052892)
124. Sutherland GR, Bain AD. Culture of cells from the urine of newborn children. Nature 239: 231, 1972.
125. Syres K, Harrison F, Tadlock M, Jester JV, Simpson J, Roy S, Salomon DR, Cherqui S. Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood 114: 2542-2552, 2009.
126. Taranta A, Petrini S, Palma A, Mannucci L, Wilmer MJ, De Luca V, Diomedi-Camassei F, Corallini S, Bellomo F, van den Heuvel LP, Levtchenko EN, Emma F. Identification and subcellular localization of a new cystinosin isoform. Am J Physiol Renal Physiol 294: F1101-F1108, 2008.
127. Taranta A, Wilmer MJ, van den Heuvel LP, Bencivenga P, Bellomo F, Levtchenko EN, Emma F. Analysis of CTNS gene transcripts in nephropathic cystinosis. Pediatr Nephrol 25: 1263-1267, 2010.
128. The Cystinosis Collaborative Research Group. Linkage of the gene for cystinosis to markers on the short arm of chromosome 17. Nat Genet 10: 246-248, 1995.
129. Thoene JG, Lemons R. Modulation of the intracellular cystine content of cystinotic fibroblasts by extracellular albumin. Pediatr Res 14: 785-787, 1980.
130. Thoene JG, Lemons RM. Cystine accumulation in cystinotic fibroblasts from free and protein-linked cystine but not cysteine. Biochem J 208: 823-830, 1982.
131. Thoene JG, Oshima RG, Crawhall JC, Olson DL, Schneider Cystinosis JA. Intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest 58: 180-189, 1976.
132. Tietze F, Butler JD. Elevated cystine levels in cultured skin fibroblasts from patients with I-cell disease. Pediatr Res 13: 1350-1355, 1979.
133. Tomlinson PA, Dalton RN, Hartley B, Haycock GB, Chantler C. Low molecular weight protein excretion in glomerular disease: a comparative analysis. Pediatr Nephrol 11: 285-290, 1997.
134. Touchman JW, Anikster Y, Dietrich NL, Maduro VVB, McDowell G, Shotelersuk V, Bouffard GG, Beckstrom-Sternberg SM, Gahl WA, Green ED. The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion. Genome Res 10: 165-173, 2000.
135. Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, Van't Hoff W, Antignac C. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18: 319-324, 1998.
136. Van Biervliet JP, Bruinvis L, Ketting D, De Bree PK, Van der HC, Wadman SK. Hereditary mitochondrial myopathy with lactic acidemia, a De Toni-Fanconi-Debre syndrome, and a defective respiratory chain in voluntary striated muscles. Pediatr Res 11: 1088-1093, 1977.
137. Vitvitsky V, Witcher M, Banerjee R, Thoene J. The redox status of cystinotic fibroblasts. Mol Genet Metab 99: 384-388, 2010.
138. Wamelink MM, Struys EA, Jansen EE, Levtchenko EN, Zijlstra FS, Engelke U, Blom HJ, Jakobs C, Wevers RA. Sedoheptulokinase deficiency due to a 57-kb deletion in cystinosis patients causes urinary accumulation of sedoheptulose: elucidation of the CARKL gene. Hum Mutat 29: 532-536, 2008. (Pubitemid 351536992)
139. Wang Y, Babankova D, Huang J, Swain GM, Wang DH. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension. Hypertension 52: 264-270, 2008.
140. Wang Y, Rangan GK, Tay YC, Wang Y, Harris DC. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol 10: 1204-1213, 1999.
141. Wilmer MJ, Christensen EI, van den Heuvel LP, Monnens LA, Levtchenko EN. Urinary protein excretion pattern and renal expression of megalin and cubilin in nephropathic cystinosis. Am J Kidney Dis 51: 893-903, 2008.
142. Wilmer MJ, Saleem MA, Masereeuw R, Ni L, van der Velden TJ, Russel FG, Mathieson PW, Monnens LA, van den Heuvel LP, Levtchenko EN. Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters. Cell Tissue Res 339: 449-457, 2010.
143. Wilmer MJ, van den Heuvel LP, Rodenburg RJ, Vogel RO, Nijtmans LG, Monnens LA, Levtchenko EN. Mitochondrial complex V expression and activity in cystinotic fibroblasts. Pediatr Res 64: 495-497, 2008.
144. Wilmer MJ, Willems PH, Verkaart S, Visch HJ, Graaf-Hess DE, Blom HJ, Monnens LA, van den Heuvel LP, Levtchenko EN. Cystine dimethylester model of cystinosis: still reliable? Pediatr Res 62: 151-155, 2007.
145. Wilmer MJG, Graaf-Hess A, Blom HJ, Dijkman HB, Monnens LA, van den Heuvel LP, Levtchenko EN. Elevated oxidized glutathione in cystinotic proximal tubular epithelial cells. Biochem Biophys Res Commun 337: 610-614, 2005.
146. Xaidara A, Karavitakis EM, Kosma K, Emma F, Dimitriou E, Michelakakis H. Chitotriosidase plasma activity in nephropathic cystinosis. J Inherit Metab Dis 2009.
147. Yard BA, Chorianopoulos E, Herr D, van der Woude FJ. Regulation of endothelin-1 and transforming growth factor-beta1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans. Nephrol Dial Transplant 16: 1769-1775, 2001.
148. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 53: 1608-1615, 1998.